Prevalence and types of cervical human papillomavirus among Turkish women and its relationship with demographic factors in a gynecology outpatient clinic

Purpose of investigation: The purpose of this study was to determine the prevalence of various human papillomavirus (HPV) types and its relationship with some risk factors among Turkish women. Materials and Methods: A total of 673 patients were included in the study. Cervical samples were taken from the patients for routine Pap smear and HPV DNA tests. HPV DNA was studied in the cervical smear by using the PCR method. Results: The mean age of the patients was 40 ± 10.9 years. Of all patients, 13.5% had a positive HPV DNA test. In addition, 5.1% of the patients were HPV type 16 positive, 1.5% were HPV type 18 positive, 0.6% were HPV type 31 positive, and 0.9% were HPV type 53 positive. Conclusion: Findings show that awareness should be raised among Turkish women regarding HPV infection and vaccination.

Turkish women; Human Papillomavirus, Prevalence.

[1] Reynolds M.J., et al.: “Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine”. J. Natl. Cancer Inst., 2001, 93, 284.

[2] Jin X.W., Cash J., Kennedy A.W.: “Human papillomavirus typing and the reduction of cervical cancer risk”. Cleve. Clin. J. Med., 1999, 66, 533.

[3] Munoz N., Bosch F.X., de Sanjosé S., Herrero R., Castellsague X., Shah KV., et al.: “Epidemiologic classification of human papillomavirus types associated with cervical cancer”. N. Engl. J. Med., 2003, 348, 518.

[4] Munoz N., Bosch F.X, Castellsague X., Diaz M., de Sanjosé S., Hammouda D., et al.: “Against which human papillomavirus types shall we vaccinate and screen? The international perspective”. Int. J. Cancer, 2004, 111, 278.

[5] Parkin DM., Bray F., Ferlay J., Pisani P.: “Global cancer statistics, 2002”. CA Cancer J. Clin., 2005, 55, 74.

[6] Özalp S.S., Us T., Arslan E., Öge T., Kaşifoğlu N.: “HPV DNA and Pap smear test results in cases with and without cervical pathology”. J. Turkish-German Gynecol. Assoc., 2012, 13, 8.

[7] Burd EM.: “Human papillomavirus and cervical cancer”. Clin. Microbiol. Rev., 2003, 16, 1.

[8] Schiffman M., Herrero R., Desalle R., Hildesheim A., Wacholder S., Rodriguez A.C. et al.: “The carcinogenicity of the human papillomavirus types reflects viral evolution”. Virology, 2005, 337, 76.

[9] Parkin DM.:“ The global health burden of infection-associated cancers in the year 2002”. Int. J. Cancer, 2006, 118, 3030.

[10] Bao Y.P., Li N., Smith J.S., Qiao Y.L., ACCPAB members.: “Human papillomavirus type distribution in women from Asia: a meta analysis”. Int. J. Gynecol. Cancer, 2008, 18, 71.

[11] Kulmala S.M., Shabalova I.P., Petrovitchev N., Syrjänen K.J., Gyllensten U.B., Syrjänen S.M.:“Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union”. J. Med. Virol., 2007, 79, 771.

[12] Agorastos T., Dinas K., Lloveras B., Bosch F.X., Kornegay J.R., Bontis J.N., de Sanjosé S.: “Cervical human papillomavirus infection in women attending gynaecological outpatient clinics in northern Greece”. Eur. J. Cancer Prev., 2004, 13, 145.

[13] Kroupis C., Thomopoulou G., Papathomas T.G., Vourlidis N., Lazaris A.C.: “Population-based study of human papillomavirus infection and cervical neoplasia in Athens,Greece”. Epidemiol. Infect., 2007, 135, 943.

[14] De Vuyst H., Steyaert S., Van Renterghem L., Claeys P., Muchiri L., Sitati S., et al.: “Distribution of human papillomavirus in a family planing population in Nairobi, Kenya”. Sex. Transm. Dis., 2003, 30, 137.

[15] de Sanjosé S., Almirall R., Lloveras B., Font R., Diaz M., Munoz N. et al.: “Cervical human papillomavirus infection in the female population in Barcelona, Spain”. Sex. Transm. Dis., 2003, 30, 788.

[16] Matos E., Loria D., Amestoy G.M., Herrera L., Prince M.A., Moreno J., et al.: “Prevalance of human papillomavirus infection among women in Concordia, Argentina: a population –based study”. Sex. Transm. Dis., 2003, 30, 593.

[17] Altun Z., Yarkin F., Vardar M.A., Uğuz A.H.: “Çukurova Üniversitesi Tip Fakültesi Hastanesine Başvuran Kadinlarda Genital Human Papillomavirus Enfeksiyon Prevalansi”. Turkiye Klinikleri J. Med. Sci, 2011, 31, 307.

[18] Dursun P., Senger S.S., Arslan H., Kuşçu E., Ayhan A.: “Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit”. BMC Infect. Dis., 2009, 9,191.

[19] de Sanjosé S., Diaz M., Castellsague X., Clifford G., Bruni L., Munoz N., Bosch F.X.: “Worldwide prevalance and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis”. Lancet Infect. Dis. 2007, 7, 453.

[20] Park T.C., Kim C.J., Koh Y.M., Lee K.H., Yoon J.H., Kim J.H.: “Human papillomavirus genotyping by the DNA chip in the cervical neoplasia”. DNA Cell Biol., 2004, 23, 119.

[21] Serra H., Pista A., Figueiredo P., Urbano A., Avilez F., De Oliveira C. F., et al.:“ Cervix uteri lesions and human papilloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction]”. Acta Med. Port., 2000, 13, 181.

[22] Burk R.D., Kelly P., Feldman J., Bromberg J., Vermund S.H., De-Hovitz C.A., Landesman S.H.: “Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors”. Sex. Transm. Dis., 1996, 23, 333.

[23] Dunne E.F., Unger E.R., Stenberg M., McQuillan G., Swan D.C., Patel S.S., Markowitz L.E.: “Prevalence of HPV infection among females in the United States”. JAMA, 2007, 297, 813.

[24] Gunnell A.S., Tran T.N., Torrång A., Dickman P.W., Sparén P., Palmgren J., Ylitalo N.: “Synergy between cigarette smoking and human papillomavirus type 16 in cervical cancer in situ development ”. Cancer Epidemiol. Biomarkers Prev., 2006, 15, 2141.

[25] Giuliano A.R., Sedjo R.L., Roe D.J., Harri R., Baldwi S., Papenfuss M. R., et al.: “Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States)”. Cancer Causes Control., 2002, 13, 839.

[26] Seltman K.M., Castle P.E., Guido R., Schiffman M., Wheeler C.M.: “Smoking is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA–positive women with equivocal or mildly abnormal cytology”. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 1165.

[27] Kenney, Janet W.R.N.: “Risk factors associated with genital HPV infection”. Cancer Nursing., 1996, 19, 353.

[28] Ozçelik B., Serin I.S., Gökahmetoğlu S., Basbuğ M., Erez R.: “Human papillomavirus frequency of women at low risk of developing cervical cancer: a preliminary study from a Turkish university hospital”. Eur. J. Gynaecol. Oncol., 2003, 24, 157.

[29] Hwang H.S., Park M., Lee S.Y., Kwon K.H., Pang M.G.: “Distribution and prevalence of human papillomavirus genotypes in routine pap smear of 2,470 Korean women determined by DNA chip”. Cancer Epidemiol. Biomarkers Prev., 2004, 13, 2153.

[30] Rota S., Biri A., Bozdayi G., Dinç B., Güner H.: “Screening and genotyping of human papillomavirus by PCR from cervical biopsies and smears in different patient groups”. Journal of the Turkish Microbiological Society, 2004, 34, 185.

[31] Inal M.M., Köse S., Yildirim Y., Ozdemir Y., Töz E., Ertopçu K., et al.: “The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women”. Int. J. Gynecol. Cancer., 2007, 17, 1266.

[32] Onan M.A., Taskiran C., Bozdayi G., Biri A., Erdem O., Acar A., et al.: “Assessment of human papilloma viral load of archival cervical intraepithelial neoplasia by real-time polymerase chain reaction in a Turkish population”. Eur. J. Gynaecol. Oncol., 2005, 26, 632.

[33] Tuncer Z.S., Basaran M., Ustaçelebi S., Kuzey G.M.: “High-risk human papilloma virus (HPV) infection determined by hybrid capture II assay in a Turkish university hospital outpatient clinic”. MN-Gorm., 2006, 12, 129.

[34] Safi Z., Demirezen S., Beksaç M.S., Kuzey G.M., Kocagöz T., Ustaçelebi Ş., et al.: “İnsan Papilloma Virusunun (IPV) Polimeraz Zincir Reaksiyonu Tekniği İle Servikal Ve Vajinal Akinti Örnek-lerinde Saptanmasi”. Mn-Klinik Bilimler&Doktor, 2002, 8, 112.

[35] Yildirim D., Yildirim M.E., Bakici M.Z.: “Sivas Bölgesinde Yaşayan Kadinlarda Servikal Örneklerdeki Human Papillomavirus Pozitifliği ve Genotiplerinin Sikliği”. Firat Med J., 2013, 18, 94.